(RTTNews) - Kodiak Sciences Inc. (KOD), a pre-commercial, retina-focused biotechnology company, is expected to report topline results from DAYBREAK, a Phase 3 study evaluating both Zenkuda (tarcocimab tedromer) and KSI-501 (tabirafusp alfa tedromer) in patients with wet age-relat
People (PPLI) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
(RTTNews) - Innovent Biologics, Inc. (1801.HK), a biopharmaceutical company focused on developing therapies across oncology and other major diseases, announced the expansion of the global Phase 3 MarsLight-11 study of IBI363/TAK-928 to include patients with non-squamous non-small
(RTTNews) - European stocks are seen opening on a cautious note on Monday due to continued uncertainty over the end to the U.S.-Iran war in the Middle East after U.S. President Donald Trump rejected Iran's latest proposal to reopen the Strait of Hormuz and signaled possible new m
(RTTNews) - Hyloris Pharmaceuticals SA (HYL.BR) announced that its partner AFT Pharmaceuticals Ltd. (AFT.NZ) has entered into an exclusive agreement with Mikasa Seiyaku Co Ltd. for the commercialization of Maxigesic IV in Japan.
Soybeans came back to close Friday with contracts down 1 ¾ cent in some back months to November’s 1 ½ cent gain. Trade details set to be announced Monday calmed the selling. November saw 15 ½ cent gain on the week. The cmdtyView national average Cash Bean price was up...
Corn futures found strength throughout the Friday session, as contracts closed 10-15 cents off the early lows and steady to a penny higher. December managed to post a ¾ cent gain on the week. The CmdtyView national average Cash Corn price was up 1 cent at $4.84. Limited information was...
The dollar index (DXY00 ) fell by -0.32% on Friday. The dollar was under pressure Friday after WTI crude oil prices fell more than -2%, easing inflation expectations and weighing on Fed policy. Also, strength in stocks on Friday curbed liquidity demand for the dollar. Dollar losses were limited on...
(RTTNews) - Akeso, Inc. (9926.HK), a biopharmaceutical company, announced that it has enrolled the first patient in COMPASSION-37 (AK104-311), a phase 3 trial evaluating Cadonilimab as first-line treatment for patients with HER2-negative, previously untreated, unresectable or met
(RTTNews) - Indian shares were deep in the red on Monday after U.S. President Donald Trump rejected Iran's latest proposal to reopen the Strait of Hormuz and other demands.